Analyst firms · J.P. Morgan · GDRX
J.P. Morgan GDRX price target and rating history
GoodRx Holdings Inc. (GDRX) · Technology
J.P. Morgan rates GoodRx Holdings Inc. (GDRX) Overweight with a $10 price target, as of its latest action on Mar 1, 2024. It has published 3 rating actions on GDRX since March 2022, including 2 upgrades and 0 downgrades.
- Current rating
- Overweight
- Price target
- $10
- Median target, all firms
- Too few
- Actions on GDRX
- 3
J.P. Morgan price target on GDRX
Every J.P. Morgan rating on GDRX
- Mar 1, 2024
- Nov 4, 2022
- Mar 1, 2022
How other firms rate GDRX
Each firm's latest rating and stated target in the last 12 months.
Questions about J.P. Morgan and GDRX
- What is J.P. Morgan's price target for GDRX?
- J.P. Morgan's latest stated price target for GoodRx Holdings Inc. (GDRX) is $10, from its action on Mar 1, 2024.
- What is J.P. Morgan's rating on GDRX?
- J.P. Morgan rates GDRX Overweight, a bullish rating, as of Mar 1, 2024.
- When did J.P. Morgan last change its view on GDRX?
- On Mar 1, 2024, J.P. Morgan upgrades to Overweight from Neutral, price target $7 to $10.
More GDRX rating histories
- Barclays5
- Raymond James6
- RBC Capital Markets3
- Leerink Partners4
- BofA Securities3
- TD Cowen3
- Goldman Sachs3
- Credit Suisse3
- Morgan Stanley3
All J.P. Morgan ratingsGDRX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.